China Health EBITDA margin
Cos'è EBITDA margin di China Health?
EBITDA margin di China Health Group Inc. è 135.28%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Health Care settore su HKSE rispetto a China Health
Cosa fa China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Aziende con ebitda margin simili a China Health
- Vardhman ha EBITDA margin di 132.44%
- Flow Capital ha EBITDA margin di 132.98%
- BlackRock Muni Quality Fund II Inc ha EBITDA margin di 133.65%
- Chesapeake Granite Wash Trust ha EBITDA margin di 134.38%
- Rand Capital ha EBITDA margin di 134.64%
- Apollo Tactical Income Fund Inc ha EBITDA margin di 134.87%
- China Health ha EBITDA margin di 135.28%
- Clough Global Dividend and Income Fund ha EBITDA margin di 135.50%
- Calamos Global Dynamic Income Fund ha EBITDA margin di 136.23%
- Atul Ltd ha EBITDA margin di 136.25%
- Midwich Plc ha EBITDA margin di 137.18%
- BlackRock Munienhanced Fund Inc ha EBITDA margin di 137.19%
- Africa Oil ha EBITDA margin di 137.63%